CUMYL-THPINACA

CUMYL-THPINACA
Systematic (IUPAC) name
	N-(1-Methyl-1-phenylethyl)-1-(tetrahydro-2H-pyran-4-yl)methyl-1H-indazole-3-carboxamide
Clinical data
Legal status	CA: Schedule II; Illegal in China and Sweden;
Identifiers
CAS Number	1400742-50-8
PubChem	CID 86273679
Chemical data
Formula	C23H27N3O2
Molar mass	377.5 g/mol
	SMILES O=C(NC(C)(C)C1=CC=CC=C1)C2=NN(CC3CCOCC3)C4=C2C=CC=C4 ;
	InChI InChI=1S/C23H27N3O2/c1-23(2,18-8-4-3-5-9-18)24-22(27)21-19-10-6-7-11-20(19)26(25-21)16-17-12-14-28-15-13-17/h3-11,17H,12-16H2,1-2H3,(H,24,27) ; Key:HINCNLQQLQFMRD-UHFFFAOYSA-N ;

CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid.^[1] CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB₁, having an EC₅₀ of 0.1nM for human CB₁ receptors and 0.59nM for human CB₂ receptors.^[2]

Legal status[edit]

Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.^[3]

As of October 2015 CUMYL-THPINACA is a controlled substance in China.^[4]

^ "CUMYL-THPINACA". Cayman Chemical. Retrieved 11 July 2015.
^ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.